U.S. market Closed. Opens in 17 hours 4 minutes

ADMA | ADMA Biologics, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 17.70 - 18.70
52 Week Range 3.06 - 19.34
Beta 0.89
Implied Volatility 31.70%
IV Rank 6.25%
Day's Volume 5,501,474
Average Volume 3,826,595
Shares Outstanding 233,083,000
Market Cap 4,242,110,600
Sector Healthcare
Industry Biotechnology
IPO Date 2013-10-17
Valuation
Profitability
Growth
Health
P/E Ratio 130.00
Forward P/E Ratio N/A
EPS 0.14
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 624
Country USA
Website ADMA
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
*Chart delayed
Analyzing fundamentals for ADMA we got that it has average fundamentals where Valuation is considered to be significantly overvalued, Profitability is poor, Growth is good and Health is strong. For more detailed analysis please see ADMA Fundamentals page.

Watching at ADMA technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on ADMA Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙